Merck is in deep negotiations to acquire cancer drug manufacturer HARPOON Therapeutics for approximately $700 million
我放心你带套猛
发表于 2024-1-8 14:01:17
285
0
0
Merck is in deep negotiations to acquire cancer drug manufacturer HARPOON Therapeutics for approximately $700 million.
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- AstraZeneca acquires a Chinese cancer drug developer with a transaction value of approximately $1.2 billion
- TSMC's CoWoS Capacity Full Load AMD Seeks Cooperation with Other CoWoS Packaging Capability Manufacturers
- Amazon abandons $1.4 billion acquisition of sweeping robot manufacturer iRobot and plans to lay off 31% of employees
- Olio manufacturer fined over 2.6 billion yuan for violating EU antitrust laws
- Aircraft manufacturers using counterfeit titanium components? Boeing and Airbus response: After analysis, the in-service fleet has not been affected
- Merck's small molecule cancer drug, acquired for over $1.3 billion, launches Phase 3 clinical trials in China
- Bristol Myers Squibb's original tumor treatment drug Abraxane has been officially launched in China
- US chip manufacturer Wolfspeed plans to receive $750 million in funding from the US Department of Commerce
- Google has reached a strategic partnership with domestic consumer grade AR glasses manufacturer XREAL
- The sharp drop in the early morning has caused multiple circuit breakers! Technology instrument manufacturer SOBR SAFE fell more than 72% at its lowest point during trading
